THE RELATIONSHIP BETWEEN DOCTORS AND REPRESENTATIVES OF THE PHARMACEUTICAL BUSINESS IN MODERN SOCIETY

Authors

Tadjikhodjaeva R.N. Nobel Pharmsanoat

Keywords:

exchange of information, supporting continuous medical education

Abstract

The relationship between doctors and representatives of the pharmaceutical industry is a fundamental element of the modern healthcare system, fostering a seamless exchange of information, supporting continuous medical education, and improving patient care. Over the last century, this partnership has evolved in response to the expanding needs of healthcare, beginning as a primarily educational collaboration. In its early stages, representatives shared essential knowledge about new medications, primarily antibiotics and vaccines, which played a crucial role in the fight against infectious diseases such as tuberculosis and polio. This initial focus on safety and effective application established the groundwork for a relationship that now encompasses a broad range of therapeutic areas and serves as a bridge between scientific research and practical, clinical applications

References

1,Relman, A. S. (1980). "The new medical-industrial complex." New England Journal of Medicine, 303(17), 963-

2.Bero, L. A., & Choudhry, N. K. (2005). "Educational interventions to improve the quality of prescribing: A

systematic review." Annals of Internal Medicine, 143(6), 445-454.

3.Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., et al. (2006). "Health

industry practices that create conflicts of interest: A policy proposal for academic medical centers." JAMA,

(4), 429-433.

Chren, M. M., & Landefeld, C. S. (1994). "Physicians' behavior and their interactions with drug companies: A

controlled study of physicians who requested additions to a hospital formulary." JAMA, 271(9), 684-689..

5.Accreditation Council for Continuing Medical Education. (2018). "CME's role in the development of professional

competencies: A review." Journal of Continuing Education in the Health Professions, 38(1), 45-57.

6.Spurling, G. K., Mansfield, P. R., Montgomery, B. D., Lexchin, J., Doust, J., Othman, N., & Vitry, A. I. (2010).

"Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: A

systematic review." PLOS Medicine, 7(10), e1000352.

Frenkel, L., & Swartz, M. K. (2007). "The role of continuing medical education in the quality improvement of

clinical practice." Pediatric Clinics of North America, 54(4), 1099-1115.

Shaughnessy, A. F., Slawson, D. C., & Bennett, J. H. (1994). "Becoming an information master: A guidebook

for practicing evidence-based medicine." Journal of Family Practice, 39(5), 489-499.

Lomas, J., Anderson, G. M., & Domnick-Pierre, K. (1989). "Do physicians use information to change their

practice?" New England Journal of Medicine, 321(10), 645-652.

10.National Institute for Health and Care Excellence (NICE). (2020). "Guidelines for safe prescribing and

medication management." NICE Guidelines.

Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice.

(2009). "Conflict of interest in medical research, education, and practice." National Academies Press.

Fitz, C. M., & Pantell, R. H. (2000). "Continuing medical education: Moving beyond minimal standards to achieve

quality improvement." Journal of General Internal Medicine, 15(10), 751-755

Downloads

Published

2024-11-09

How to Cite

Tadjikhodjaeva R.N. (2024). THE RELATIONSHIP BETWEEN DOCTORS AND REPRESENTATIVES OF THE PHARMACEUTICAL BUSINESS IN MODERN SOCIETY. European Journal of Research Development and Sustainability, 5(11), 1-3. Retrieved from https://scholarzest.com/index.php/ejrds/article/view/4801